JOHN J CAMPBELL
Broker in Cambridge, MA
License number
Massachusetts 17363
Issued Date
Jan 1, 1960
Expiration Date
Aug 26, 2000
Type
Broker
Address
Address
Cambridge, MA 02138
Professional information
North American Sales Manager At Mvtec, Llc
Position:
North American Sales Manager at MVTec, LLC
Location:
Greater Boston Area
Industry:
Industrial Automation
Work:
MVTec, LLC
- Cambridge, MA since Jan 2009
-
North American Sales Manager
GSI Group Inc
Apr 2001 - Dec 2008
-
Sales Manager
GSI Group Inc
Sep 1997 - Apr 2001
-
Sr. Applications Engineer
Education:
Lafayette College 1993 - 1997
BS, Electrical Engineering
BS, Electrical Engineering
Skills:
Image Processing, Machine Vision, New Business Development, Account Management, Sales Management, Drums, Percussion, Customer Relations, HALCON, Sales, International Sales
Interests:
Drumming, music, cooking, soccer, baseball, skiing, history.
Heteroaryl Compounds And Methods Of Use Thereof
US Patent:
2012017, Jul 12, 2012
Filed:
Jan 10, 2012
Appl. No.:
13/347541
Inventors:
John Emmerson CAMPBELL - Cambridge MA, US
Philip JONES - Danvers MA, US
Michael Charles HEWITT - Somerville MA, US
Philip JONES - Danvers MA, US
Michael Charles HEWITT - Somerville MA, US
Assignee:
Sunovion Pharmaceuticals Inc. - Marlborough MA
International Classification:
A61K 31/5383, A61K 31/519, A61K 31/437, C07D 498/14, C07D 487/04, C07D 471/04, C07D 491/147, A61P 3/04, C07D 471/14, A61P 25/00, A61P 3/00, A61P 25/18, A61P 25/28, A61P 25/22, A61P 25/24, A61P 25/16, A61P 25/20, A61P 3/10, A61K 31/4985
US Classification:
5142302, 514249, 514250, 51425931, 514293, 544101, 544263, 544345, 544350, 546 82, 546 83
Abstract:
Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes.
Heteroaryl Compounds And Methods Of Use Thereof
US Patent:
2013015, Jun 20, 2013
Filed:
May 26, 2011
Appl. No.:
13/700051
Inventors:
John Emmerson Campbell - Cambridge MA, US
Michael Charles Hewitt - Somerville MA, US
Philip Jones - Danvers MA, US
Linghong Xie - Southborough MA, US
Michael Charles Hewitt - Somerville MA, US
Philip Jones - Danvers MA, US
Linghong Xie - Southborough MA, US
Assignee:
SUNOVION PHARMACEUTICALS INC - Marlborough MA
International Classification:
C07D 403/06, C07D 409/06, C07D 405/14, C07D 409/14, C07D 498/04, C07D 417/06, C07D 413/06, C07D 487/04, C07D 471/14, C07D 471/04, C07D 401/14
US Classification:
51421021, 544353, 514249, 544354, 544284, 51426623, 544279, 5142641, 544287, 546152, 514314, 5142662, 544350, 544263, 51425931, 546 82, 514293, 544101, 5142298, 544405, 51425505, 544322, 544295
Abstract:
Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes.
Multicyclic Compounds And Methods Of Use Thereof
US Patent:
2013010, May 2, 2013
Filed:
Dec 3, 2010
Appl. No.:
13/513176
Inventors:
Liming Shao - Lincoln MA, US
John Emmerson Campbell - Cambridge MA, US
Michael Charles Hewitt - Somerville MA, US
Una Campbell - Marlborough MA, US
Taleen G. Hanania - Valhalla NY, US
John Emmerson Campbell - Cambridge MA, US
Michael Charles Hewitt - Somerville MA, US
Una Campbell - Marlborough MA, US
Taleen G. Hanania - Valhalla NY, US
Assignee:
Psychogenics Inc. - Tarrytown NY
Sunovion Pharmaceuticals Inc. - Marlborough MA
Sunovion Pharmaceuticals Inc. - Marlborough MA
International Classification:
C07D 495/04, A61K 31/55, C07D 495/20, A61K 31/435, A61K 31/381, A61K 45/06
US Classification:
51421703, 549 50, 514443, 546 17, 514278, 540596
Abstract:
Provided herein are multicyclic compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. The compounds provided herein are useful for the treatment, prevention, and/or management of various neurological disorders, including but not limited to, psychosis and schizophrenia.